OC 61.3 CS585 is a Novel and Highly Selective IP Receptor Agonist for Prevention of Thrombosis
Sylviane Lambert(University of Michigan), Michael Holinstat(Thomas Jefferson University), Andrew Rickenberg(University of Michigan), Adriana Yamaguchi(University of Michigan), Livia Stanger(University of Michigan), B. Dahlof, N. Bergh, P. Yalavarthi(University of Michigan)
Cited by 0
Related Papers
An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis
|Cell|2024|102
Protein Kinase C Regulation of 12-Lipoxygenase-Mediated Human Platelet Activation
|Molecular Pharmacology|2011|44
Antiplatelet strategies: past, present, and future
|Journal of Thrombosis and Haemostasis|2023|39
Irreversible Platelet Activation Requires Protease-Activated Receptor 1-Mediated Signaling to Phosphatidylinositol Phosphates
|Molecular Pharmacology|2009|36
DHA 12‐LOX‐derived oxylipins regulate platelet activation and thrombus formation through a PKA‐dependent signaling pathway
|Journal of Thrombosis and Haemostasis|2020|36